Amplifon SpA
MIL:AMP
ROE
Return on Equity (ROE) measures how effectively a company generates profit from shareholders` equity. It shows how much net income is earned for each dollar invested by shareholders.
Return on Equity (ROE) measures how effectively a company generates profit from shareholders` equity. It shows how much net income is earned for each dollar invested by shareholders.
Peer Comparison
| Country | Company | Market Cap | ROE | ||
|---|---|---|---|---|---|
| IT |
|
Amplifon SpA
MIL:AMP
|
2.8B EUR |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
118.6B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
70.9B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
70.8B USD |
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
53.3B USD |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
34.7B AUD |
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.7B USD |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.9B CNY |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.2B CNY |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
67.1B HKD |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
Market Distribution
| Min | -1 509.2% |
| 30th Percentile | 6.8% |
| Median | 12.8% |
| 70th Percentile | 18.5% |
| Max | 8 524.1% |
Other Profitability Ratios
Amplifon SpA
Glance View
Amplifon SpA, a global leader in hearing solutions, crafts its story around a mission to enhance auditory experiences for individuals worldwide. The company, founded in 1950 by Algernon Charles Holland in Milan, Italy, began as a modest venture but evolved into a dominant force in the audiology market. Amplifon operates through an extensive network of clinics and service centers, boasting a widespread presence across Europe, the Americas, Asia-Pacific, and Africa. Each location serves as a hub where highly trained audiologists and specialists offer personalized hearing assessments and consultations. This localized approach allows the company to cater uniquely to each customer's needs, delivering tailored solutions such as hearing aids, devices, and accessories from leading brands, as well as a suite of supportive services. The company's business model effectively harnesses a comprehensive and vertically integrated structure. Amplifon generates revenue by not just selling hearing devices, but also by providing related services like fittings, aftercare, and support. This approach creates a recurring income stream, as customers often require ongoing maintenance and upgrades to their devices. Additionally, Amplifon invests heavily in research and development, ensuring its offerings incorporate the latest technological advancements. By focusing on innovation and customer satisfaction, Amplifon maintains strong relationships with both its suppliers and clientele, fortifying its position in the competitive landscape of hearing solutions. Through a combination of strategy, service, and an unwavering commitment to quality, the company continues to expand its influence and drive growth in the global market.
See Also
ROE is calculated by dividing the Net Income by the Avg Total Equity.
The current ROE for Amplifon SpA is 11.1%, which is below its 3-year median of 14.3%.
Over the last 3 years, Amplifon SpA’s ROE has decreased from 18.6% to 11.1%. During this period, it reached a low of 11.1% on Sep 30, 2025 and a high of 18.6% on Sep 30, 2022.